Author Levin, Johannes
-
2002 | Journal Article
Relaxation dynamics of deuterated formyl and isoformyl cations
Wester, R.; Hechtfischer, U.; Knoll, L.; Lange, M.; Levin, J.; Scheffel, M. & Schwalm, D. et al. (2002)
The Journal of Chemical Physics, 116(16) pp. 7000-7011. DOI: https://doi.org/10.1063/1.1461812
Details DOI WoS
-
2014 | Journal Article | Letter Note |
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset
Levin, J.; Schmidt, F.; Boehm, C.; Prix, C.; Boetzel, K.; Ryazanov, S. & Leonov, A. et al. (2014)
Acta Neuropathologica, 127(5) pp. 779-780. DOI: https://doi.org/10.1007/s00401-014-1265-3
Details DOI PMID PMC WoS
-
2015 | Journal Article | Research Paper |
Extracellular vesicle sorting of alpha-Synuclein is regulated by sumoylation
Kunadt, M.; Eckermann, K.; Stuendl, A.; Gong, J.; Russo, B.; Strauss, K. & Rai, S. et al. (2015)
Acta Neuropathologica, 129(5) pp. 695-713. DOI: https://doi.org/10.1007/s00401-015-1408-1
Details DOI PMID PMC WoS
-
2016 | Conference Abstract
Neurochemical markers in the differential diagnosis of primary progressive aphasias: Data from the German FTLD consortium
Oeckl, P.; Anderl-Straub, S.; Diehl-Schmid, J.; von Arnim, C. A. F. ; Fassbender, K.; Feneberg, E. & Fliessbach, K. et al. (2016)
Journal of Neurochemistry, 138 10th International Conference on Frontotemporal Dementias, Munich, GERMANY.
Hoboken: Wiley-blackwell.
Details WoS
-
2016 | Journal Article |
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach (vol 123, pg 439, 2016)
Levin, J.; Maass, S.; Schuberth, M.; Respondek, G.; Paul, F.; Mansmann, U. & Oertel, W. H. et al. (2016)
Journal of Neural Transmission, 123(11) pp. 1357-1358. DOI: https://doi.org/10.1007/s00702-016-1602-x
Details DOI PMID PMC WoS
-
2016 | Journal Article | Research Paper |
Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
Fellner, L.; Kuzdas-Wood, D.; Levin, J.; Ryazanov, S. ; Leonov, A. ; Griesinger, C. & Giese, A. et al. (2016)
Frontiers in Neuroscience, 10 art. 99. DOI: https://doi.org/10.3389/fnins.2016.00099
Details DOI PMID PMC WoS
-
2017 | Journal Article
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
Höglinger, G.; Respondek, G.; Stamelou, M.; Kurz, C.; Josephs, K.; Lang, A. & Mollenhauer, B. et al. (2017)
Movement Disorders, 32(6) pp. 853-864. DOI: https://doi.org/10.1002/mds.26987
Details DOI PMID PMC
-
2017 | Journal Article
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Respondek, G.; Kurz, C.; Arzberger, T.; Compta, Y.; Englund, E.; Ferguson, L. & Gelpi, E. et al. (2017)
Movement Disorders, 32(7) pp. 995-1005. DOI: https://doi.org/10.1002/mds.27034
Details DOI PMID PMC
-
2018 | Journal Article |
Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease
Franzmeier, N.; Düzel, E.; Jessen, F.; Buerger, K.; Levin, J.; Duering, M. & Dichgans, M. et al. (2018)
Brain: A Journal of Neurology, 141(4) pp. 1186-1200. DOI: https://doi.org/10.1093/brain/awy008
Details DOI
-
2019 | Journal Article
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Levin, J.; Maaß, S.; Schuberth, M.; Giese, A.; Oertel, W. H; Poewe, W. & Trenkwalder, C. et al. (2019)
The Lancet Neurology, 18(8) pp. 724-735. DOI: https://doi.org/10.1016/S1474-4422(19)30141-3
Details DOI
-
2019 | Journal Article | Research Paper |
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
Brendel, M.; Deussing, M.; Blume, T.; Kaiser, L.; Probst, F.; Overhoff, F. & Peters, F. et al. (2019)
Alzheimer's Research & Therapy, 11(1). DOI: https://doi.org/10.1186/s13195-019-0522-z
Details DOI
-
2019 | Journal Article |
Unraveling corticobasal syndrome and alien limb syndrome with structural brain imaging
Albrecht, F.; Mueller, K.; Ballarini, T.; Lampe, L.; Diehl-Schmid, J.; Fassbender, K. & Fliessbach, K. et al. (2019)
Cortex, 117 pp. 33-40. DOI: https://doi.org/10.1016/j.cortex.2019.02.015
Details DOI
-
2021 | Journal Article
Quantifying progression in primary progressive aphasia with structural neuroimaging
Lombardi, J.; Mayer, B.; Semler, E.; Anderl‐Straub, S.; Uttner, I.; Kassubek, J. & Diehl‐Schmid, J. et al. (2021)
Alzheimer's & Dementia,. DOI: https://doi.org/10.1002/alz.12323
Details DOI
-
2022 | Journal Article
Utility of the Repeat and Point Test for Subtyping Patients With Primary Progressive Aphasia
Seckin, M.; Ricard, I.; Raiser, T.; Heitkamp, N.; Ebert, A.; Prix, C. & Levin, J. et al. (2022)
Alzheimer Disease & Associated Disorders, 36(1) pp. 44-51. DOI: https://doi.org/10.1097/WAD.0000000000000482
Details DOI
-
2022 | Journal Article
Kosten der Diagnostik kognitiver Störungen in deutschen Gedächtnisambulanzen
Onur, O. A.; Wolff-Menzler, C. ; Arnim, C. A. F. von ; Jessen, F.; Fink, G. R.; Wiltfang, J. & Laske, C. et al. (2022)
Fortschritte der Neurologie · Psychiatrie, 90(07/08) pp. 361-367. DOI: https://doi.org/10.1055/a-1871-9889
Details DOI
-
2022 | Journal Article | Research Paper |
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
Levin, J.; Sing, N.; Melbourne, S.; Morgan, A.; Mariner, C.; Spillantini, M. G. & Wegrzynowicz, M. et al. (2022)
eBioMedicine, 80 art. S2352396422002055. DOI: https://doi.org/10.1016/j.ebiom.2022.104021
Details DOI PMID PMC
-
2023 | Journal Article |
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
Koeglsperger, T.; Rumpf, S.-L.; Schließer, P.; Struebing, F. L.; Brendel, M.; Levin, J. & Trenkwalder, C. et al. (2023)
Molecular Neurodegeneration, 18(1). DOI: https://doi.org/10.1186/s13024-023-00622-7
Details DOI